Evogene Schedules Third Quarter of 2022 Financial Results Release & Conference Call for November 17, 2022
09 November 2022, Israel: Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development announced today
Read More